News

All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone CAMBRIDGE, MA / ACCESS ...
CAMBRIDGE, MA / ACCESS Newswire / August 21, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced its participation in the ...
An update to Moderna's COVID-19 vaccine that targets the newest variants and is made entirely within Canada's borders was ...
Moderna has secured approval from Health Canada for Spikevax, its updated Covid-19 mRNA vaccine, which targets the SARS-CoV-2 ...
The Trump administration said it was terminating mRNA vaccine research and shifting focus to other approaches, including a ...
The approval keeps Moderna on track to deliver doses ahead of the 2025-2026 vaccination season. Production will take place in ...
All pre-filled syringe doses for the Canadian market will be manufactured domestically for the first time, with drug ...
Investing.com -- Moderna Inc (NASDAQ:MRNA) stock fell 5.5% and Pfizer Inc (NYSE:PFE) shares dropped 2.6% following reports from Newsweek and The Daily Beast that the Trump administration may be ...
Teams that bring a variety of experience and expertise can spot problems faster and arrive at more well-rounded, viable ...
Health Canada approves Moderna’s updated Covid-19 mRNA vaccine, Spikevax, targeting SARS-CoV-2 variant LP.8.1 ...
Biotech giant Moderna announced it will lay off 10% of its workforce in a move CEO Stéphane Bancel called “a difficult decision but necessary step forward,” in an internal memo sent to employees on ...
TORONTO - Health Canada has authorized updated COVID-19 vaccines by Pfizer and BioNTech and by Moderna for use this ...